Practices

Stimulants are not the only licensed route. Atomoxetine, guanfacine and clonidine all hold approval for attention difficulties, and they matter when a stimulant cannot be used.

They usually sit after stimulants rather than beside them, because the comparative evidence still favours stimulants overall. They come into their…

A heart tracing before starting a stimulant is not routinely needed. Some practices still ask for one anyway, and it can hold a child up for months.

What the guidance asks for is a careful history and an examination, with a tracing kept for children whose own or family history warrants it. An…

Licences start at six years old, and that number comes from how trials have to be run rather than from a safety finding. Younger children do get treated where the case is strong.

Trials need the child's own assent alongside a parent's consent, and assent means a form the child can read and understand, so studies stop where…

There are three families of medicine here: the stimulants, the agents that work on noradrenaline alone, and the alpha-2 drugs that began as blood pressure treatments. Three routes rather than three brands of one thing.

That matters when one of them does not work or cannot be used. A poor response inside one family says little about the others, so a sequence has…